Abstract

PT32 Cost-Effectiveness of Lorlatinib in Second-Line Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer in China

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Novel agents in the treatment of lung cancer: conference summary statement.
Thomas J Lynch ... Rafael Rosell
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 10
Thomas J Lynch, et. al.Thomas J Lynch ... Rafael Rosell
15 Jun 2004
New Horizons in Chemotherapy: Platforms for Combinations in First-Line Advanced Non-small Cell Lung Cancer
Rogerio C Lilenbaum
Journal of Thoracic Oncology | VOL. 3
Rogerio C LilenbaumRogerio C Lilenbaum
01 Jun 2008
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis.
Qiao Liu ... Lidan Yi
Drug Investigation | VOL. 40
Qiao Liu, et. al.Qiao Liu ... Lidan Yi
02 Nov 2019
Chinese expert consensus on antiangiogenic drugs for advanced non-small cell lung cancer (2020 Edition)
Chinese journal of oncology | VOL. 42
23 Dec 2020
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Methods for measuring and valuing informal care: A systematic review and meta-analysis in stroke
Neha Das ... Lan Gao
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Neha Das, et. al.Neha Das ... Lan Gao
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
View more papers